Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Preferred Shares (2017 - 2026)

Sunshine Biopharma filings provide 10 years of Preferred Shares readings, the most recent being $13000.0 for Q4 2025.

  • On a quarterly basis, Preferred Shares changed 0.0% to $13000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $13000.0, a 0.0% change, with the full-year FY2025 number at $13000.0, changed 0.0% from a year prior.
  • Preferred Shares hit $13000.0 in Q4 2025 for Sunshine Biopharma, roughly flat from $13000.0 in the prior quarter.
  • In the past five years, Preferred Shares ranged from a high of $100000.0 in Q1 2021 to a low of $1000.0 in Q1 2022.
  • Median Preferred Shares over the past 5 years was $13000.0 (2024), compared with a mean of $25600.0.
  • Biggest five-year swings in Preferred Shares: plummeted 99.0% in 2022 and later surged 1200.0% in 2024.
  • Sunshine Biopharma's Preferred Shares stood at $100000.0 in 2021, then plummeted by 99.0% to $1000.0 in 2022, then changed by 0.0% to $1000.0 in 2023, then surged by 1200.0% to $13000.0 in 2024, then changed by 0.0% to $13000.0 in 2025.
  • The last three reported values for Preferred Shares were $13000.0 (Q4 2025), $13000.0 (Q3 2025), and $13000.0 (Q2 2025) per Business Quant data.